Centinel Spine’s revenue was more than $32 million during the third quarter, a 42% year-over-year increase, according to financial results posted Oct. 28.
Five things to know:
1. Centinel Spine also saw record global revenue for its cervical total disc replacement implants with nearly $20 million. That’s a 34% increase year over year.
2. U.S. prodisc sales were nearly $27 million, a 46% increase year over year.
3. International sales grew 28% year over year with more than $5 million.
4. In the U.S., Centinel Spine’s total surgeon user base grew 50% year over year.
5. “Our continued momentum reflects the exceptional dedication of our team and the growing global demand for our prodisc technology,” CEO Steve Murray said in a news release. “Achieving strong revenue growth and double-digit EBITDA margins, along with landmark regulatory milestones—such as 2-level FDA PMA approval and MDR certification for our key cervical products—reinforces our position as the global leader in total disc replacement. As more surgeons adopt our cervical and lumbar technologies and our international presence expands, we remain committed to transforming patient care with the most clinically-proven total disc replacement solutions in the world.”
